017810 — Pulmuone Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedSmall CapNeutral

Market Cap
KR₩450bn
Enterprise Value
KR₩2tn
Revenue
KR₩3tn

Annual income statement for Pulmuone Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,381,451	2,311,200	2,518,896	2,838,304	2,993,468
Cost of Revenue
Gross Profit	590,024	611,494	656,235	700,419	759,041
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,352,814	2,270,427	2,492,007	2,813,313	2,940,415
Operating Profit	28,637	40,773	26,890	24,991	53,053
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,886	17,955	13,509	-18,413	14,312
Provision for Income Taxes
Net Income After Taxes	-7,535	11,834	304	-36,967	13,358
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,492	16,280	13,357	-18,602	19,516
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,092	16,280	5,326	-29,957	9,365
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	70.5	503	304	-803	526
Dividends per Share